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a  b  s  t  r  a  c  t
INTRODUCTION:  Hepatocellular  carcinoma  (HCC)  occurring  in  pregnancy  is  quite  rare.  The  prognosis  is
usually  poor  because  of a  delay  in  diagnosis.  Reported  cases  of  HCC  in  pregnancy  are  largely  isolated
with  no  large  experience.  Thus  the  effect  of  pregnancy  on the  prognosis  of  patients  with  HCC and  the  risk
factors  of  developing  HCC  in  pregnancy  are  not  well  documented.  Our  aim  was  to review our experience
with  management  of four  young  pregnant  women  with  HCC.
PRESENTATION  OF  CASE:  Laboratory  tests  were  performed  before  surgery.  We  analyzed  the  effects  of
age, hepatitis  B surface  antigens  status,  cirrhosis  at presentation,  gestational  age  of fetus,  and  maternal
outcome.
DISCUSSION:  Increase  in alpha-fetoprotein  (AFP)  level  was somewhat  useful  for diagnosis.  Three  patients
died  in 5 months,  6 months,  and 24  months  from  HCC  recurrence,  and  another  patient  is alive  without
disease  12 months  postoperatively.
CONCLUSION:  Surgery  for HCC  during  pregnancy  should  be similar  to  that  for non-pregnant  women.
Complete  excision  of  tumor  without  termination  of  pregnancy  provides  the  greatest  chance  of survival
for  women  with  HCC  during  pregnancy  but  depends  on  gestational  age  of  the  fetus.  Adjuvant  treatments
are  required  to  improve  the  long-term  results  of this  type  of  surgery.  The  28-week  gestational  week  is
a  critical  point  of  fetal  maturation  which  is  very  important  in  deciding  whether  pregnancy  should  be
terminated  or  not.  The  pregnancy  was  terminated  in  two of  our  patients  when  spontaneous  rupture  of
HCC was diagnosed  to  save  the  mother’s  life.
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1. Introduction
Hepatocellular carcinoma (HCC) occurring in pregnancy is rare.
Since 1957, less than 50 cases have been reported worldwide.1,2
A comprehensive review by Lau et al.5 reported ﬁve cases and
analyzed an additional 23 cases of HCC in pregnancy reported in
the literature. Only three mothers underwent liver resection. Live
infants were developed in 57% of cases but the maternal outcome
was grave. The median survival was  shorter than patients who  were
not pregnant. Choi et al.1 reported four cases and analyzed an addi-
tional 44 cases of HCC in pregnancy. Only 16 mothers got the chance
for liver resection. Their overall 6-month and 1, 2, and 3-year sur-
vival rates were 50%, 30%, 18%, and 14% respectively. It appears that
the morbidity and mortality of HCC during pregnancy has improved
over time as the diagnosis tended to be made earlier and patients
tended to receive resection and other treatments.6 El-Serat et al.7
ssociates Ltd. This is an open access article under the CC BY-NC-SA license
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Tig. 1. Magnetic resonance imaging (MRI) showed there was a liver tumor with the
ize of 10 × 10 × 10 cm3 in the middle liver and a normal male infant of 2.9 kg weight
n the uterus below the liver.
eported that HCC were more aggressive with an overall one-year
urvival of only 23%. Pregnancy with HCC is believed to impart
 worse prognosis than in non-pregnant women.1,7 Also, in the
ajority of reported cases, pregnancy was terminated when cancer
as diagnosed. Our article describes a single center experience with
hree patients with pregnancy-associated HCC in the Eastern Hepa-
obiliary Surgery Hospital between January 2002 and December
012 and includes the occurrence of rupture and hemorrhage dur-
ng the puerperal state in two of the four patients.
. Case reports
Case 1A 27-year-old woman with her ﬁrst pregnancy presented
ith HCC with 32-weeks’ gestation. She was admitted because of
ight upper quadrant pain. Laboratory ﬁndings included a total
ilirubin of 3.5 mol/L, albumin 33.7 g/L, alanine aminotransferase
ALT) 58 iu/L, aspartate aminotransferase (AST) 102 iu/L, and alka-
ine phosphatase (ALP) 97 iu/L. She was HBsAg (+) anti-HBe (+)
nti-HBc (+) HBV-DNA (−). Her alpha-fetoprotein (AFP) was greater
han 1000 U/L. Abdominal ultrasonography showed a hypoechoic
umor, 10 cm in size in the middle liver. Magnetic resonance imag-
ng (MRI) conﬁrmed a huge lesion in the middle of her liver,
0 × 10 × 10 cm3 (Fig. 1). The plan was to carry out a synchronous
iddle hepatectomy and C-section.
A normal male infant of 2.9 kg was delivered by Cesarean
ection. Subsequently, middle lobectomy (segmentectomy of IV,
, and VIII) and cholecystectomy was performed via a subcostal
blique incision. During operation, 30 ml  of non-coagulative liquid
as present in the abdominal cavity; the liver was not cirrhotic.
he patient and baby recovered well after surgery. The pathologicPEN  ACCESS
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diagnosis was HCC with clear surgical margins (T1N0M0). One
month later, computed tomography (CT) showed multiple tumor
recurrences in the liver and the patient died 6 months later. The
infant remains well but is positive for the hepatitis B virus surface
antigen.Case 2A 24-year-old pregnant woman at the gestational
age of 26 weeks was  admitted because of right upper quadrant
pain. Abdominal ultrasonography revealed a tumor in the left lobe
of the liver. Laboratory ﬁndings included normal liver function tests
but she was  positive for hepatitis B surface antigen and her AFP was
greater than 1000 U/L. CT showed a 17 cm lesion with an irregular
margin in the left liver and some free peritoneal ﬂuid. The diagnosis
was made of spontaneous rupture of primary liver cancer, and she
underwent Cesarean section where a stillborn fetus weighing 1500
grams was removed. Subsequently a left hepatic lobectomy was
performed for a 20 × 17 × 16 cm3 lesion in a non-cirrhotic liver.
During operation, 200 ml  of a non-coagulative liquid was present
in the abdominal cavity. Histopathology showed a HCC with a
free resection margin. The patient recovered uneventfully and
was discharged home on postoperative day number 8. The patient
died in 2 years from HCC recurrence.Case 3A 23-year-old pregnant
woman at the gestational age of 16 weeks was admitted because of
right upper quadrant pain. Abdominal ultrasonography revealed
a tumor in the left lobe of the liver. Laboratory ﬁndings included
normal liver function tests but she was positive for hepatitis B
surface antigen and her AFP was greater than 1000 U/L. CT showed
a 7 cm lesion in the left liver. She underwent Cesarean section
where a stillborn fetus of 4 months was  removed. Subsequently
a left hepatic lobectomy was performed for a 6 × 7 × 7 cm3 lesion
in a non-cirrhotic liver. Histopathology showed a HCC with a free
resection margin. The patient was  discharged home on postopera-
tive day number 7. After operation, the patient received two  times
of transarterial chemoembolization (TACE) from HCC recurrence
and died in 5 months after operation.Case 4A 40-year-old female
with a two-year history of chronic hepatitis B presented with
her ﬁrst pregnancy at 24 weeks of gestation. Routine abdominal
ultrasonography revealed incidentally a tumor mass in the left
lobe of the liver. Laboratory values showed positivity for hepatitis
B surface antigen and an AFP greater than 1000 U/L. MRI  showed
a 7 cm space-occupying lesion with a regular margin in the left
lobe of the liver. Two  weeks before operation, an abortion was
performed, and then later a hemihepatectomy was carried out.
No cirrhosis was  found during the operation. Histopathology
showed HCC with a clear resection margin. The patient recovered
uneventfully and was  discharged home on postoperative day
seven. During the following period, the serum alpha-fetoprotein
level has remained within the normal range and, at present, the
patient remains free of HCC 12 months after hepatectomy.
3. Discussion
The concomitant presence of HCC during pregnancy is rare, but
must be considered in populations with a high prevalence of expo-
sure to Hepatitis B virus. The exposure to long-term estrogen and
progesterone therapies in women of childbearing age for contra-
ception may  further predispose women  who are hepatitis B antigen
positive to development of HCC. Similarly, a family history of HCC is
also pertinent.1,10 During pregnancy, the large amounts of human
chorionic gonadotropin (HCG), estrogen and placental lactogen
secreted from the placenta are believed to promote the growth and
reproduction of cancer cells, thus aggravating the aggressiveness
of the underlying HCC.8–12The diagnosis of HCC during pregnancy can also be difﬁcult.
Many of the physiologic symptoms of pregnancy can be similar
to those of an underlying HCC,13–15 such as fatigue, nausea, and
vomiting, leading to a delay in diagnosis. Similarly as pregnancy
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rogresses, a palpable liver mass becomes less evident as with our
atients despite large liver mass. Indeed, in the later stages of preg-
ancy, the diagnosis of HCC is especially difﬁcult and may  only be
ade at the time of delivery or soon thereafter.
Serum liver enzymes and even serum AFP levels may  be of
ittle help.1,11,14,16–18 Liver function tests are often normal,13,14
nd maternal AFP levels are increased normally during pregnancy
econdary to placental spillover from the fetus into the maternal
irculation; peak maternal AFP levels occur at 30 weeks gestation
nd after delivery return to normal about two weeks later.
B-mode ultrasonography is probably the best modality during
regnancy when hepatic pathology is suspected. When HCC is sus-
ected, then CT or MRI  is strongly suggested because one would
ot want to delay the diagnosis.19,20
The treatment possibilities for HCC during pregnancy include
esection, TACE, systemic chemotherapy, radiofrequency ablation,
nd ethanol injection. Despite these options, resection represents
he best potentially curative therapy. But both mother and fetus
eed to be considered. The 28th gestational week is the critical
oint of fetal maturation. Premature birth is deﬁned as birth before
he 28th week of gestation, before which survival of the baby is
uch less.20,21 Therefore, gestational age of the baby plays a major
ole in decision making.
For pregnancies in the ﬁrst trimester, maternal survival usually
akes precedence. Delay in resection until the 28th week is futile,
nd neither mother nor baby will survive.2,5,7 Therefore, the usual
uggestion is for the pregnancy to be terminated and the mother to
ndergo liver resection. In contrast, for pregnancies in the second
rimester, the anesthesia is safer for the fetus and hepatic resection
an be attempted with preservation of the pregnancy. Some inves-
igators, however have suggested that prior to 28 weeks gestation,
he pregnancy should be terminated and the mother treated by
epatic resection. A thorough multidisciplinary discussion with the
urgeon, oncologist, and obstetrician is necessary to decide appro-
riate timing of the liver resection in relationship to the potential
iability of the fetus; for smaller neoplasms, a delay in resection to
llow more maturity of the fetus may  be a reasonable approach.
n the third trimester, hepatic resection should not be delayed; the
etus can be delivered by Cesarean section simultaneously with the
epatectomy.
Tumor rupture and hemorrhage represent a life-threatening
omplication. Indeed, about 10% of HCC during pregnancies are
omplicated by tumor rupture2,5,20,22 believed, in part, related to
umor liquefaction necrosis which, in addition to the increased
ntra-abdominal pressure secondary to the pregnancy, predisposes
o rupture and hemorrhage. Control of hemorrhage and main-
enance of vital signs are paramount. Emphasis then switches
o preservation of the mother with hepatic resection and either
ermination of the pregnancy or Cesarean section depending on
estational age of the fetus.
Finally, outcomes of HCC during pregnancy have not been good.
hether pregnancy with its associated hormonal effects promotes
umor is unclear.23,24 Long-term survival of the mother after hep-
tectomy is less good compared to patients who are not pregnant,
ecause of a few cases, which need research in the further.
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Key learning points
• The effect of pregnancy on the prognosis of patients with HCC and
the risk factors of developing HCC in pregnancy are not well docu-
mented. Increase in alpha-fetoprotein (AFP) level was somewhat
useful for diagnosis. Three patients died from HCC recurrence,
and another patient is alive without disease 12 months postop-
eratively.
• Surgery for HCC during pregnancy should be similar to that for
non-pregnant women. Complete excision of tumor without ter-
mination of pregnancy provides the greatest chance of survival
for women  with HCC during pregnancy but depends on gesta-
tional age of the fetus. The 28-week gestational week is a critical
point of fetal maturation which is very important in deciding
whether pregnancy should be terminated or not.
• Adjuvant treatments are required to improve the long-term
results of this type of surgery.
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